DGAP-News
B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN, AnalytiCon and Roquette sign a strategic partnership for the development of next generation natural sweetening solutions
DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG /
Key word(s): Alliance
B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN,
AnalytiCon and Roquette sign a strategic partnership for the development of
next generation natural sweetening solutions
29.08.2016 / 08:30
The issuer is solely responsible for the content of this announcement.
Key word(s): Alliance
B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN,
AnalytiCon and Roquette sign a strategic partnership for the development of
next generation natural sweetening solutions
29.08.2016 / 08:30
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
BRAIN, AnalytiCon and Roquette sign a strategic partnership for the
development of next generation natural sweetening solutions
- The three partners form the DOLCE consortium to address sugar and
sweetening solutions challenge in different markets and applications.
- Many of the largest Fortune 500 global consumer product goods companies
are known to have significant interest in this field
Zwingenberg, Potsdam (Germany) and Lestrem (France), August 29, 2016: The
bioeconomy company BRAIN AG (ISIN DE0005203947 / WKN 520394), the natural
product specialist AnalytiCon Discovery GmbH and Roquette, a global leader
in specialty food ingredients from plant-based raw materials, announced
today a strategic partnership under the form of a consortium by the name
DOLCE. Within this unique strategic partnership, the partners will jointly
develop natural sweeteners and sweet taste enhancers with the goal to
achieve sugar- and calorie reduction in a variety of food and beverages.
These developments will benefit the global market and will address pressing
needs in terms of sugar replacement.
Always striving for innovation, within the DOLCE consortium, Roquette
intends to benefit from the proprietary BRAIN screening technology and
AnalytiCon's access to a huge variety of all-natural ingredients with a
particular focus on edible plant material. Roquette's role will be to take
care of the late stage development, production and supply of the compounds
to different markets and application fields.
The goal of the DOLCE consortium is to develop cutting-edge natural sweet
taste enhancers and sweeteners for nutrition and improved food formulations
for their customers, and to deploy a brand strategy on the new solutions,
addressing the requirements of global customers. Many of the largest
Fortune 500 global consumer product goods companies (CPGC) are known to
have strong interest in this field, and the market for consumer goods and
beverages is expected to greatly benefit from the development of these new
sweetening solutions.
"In the field of food and beverages, there is a high demand for natural
BRAIN, AnalytiCon and Roquette sign a strategic partnership for the
development of next generation natural sweetening solutions
- The three partners form the DOLCE consortium to address sugar and
sweetening solutions challenge in different markets and applications.
- Many of the largest Fortune 500 global consumer product goods companies
are known to have significant interest in this field
Zwingenberg, Potsdam (Germany) and Lestrem (France), August 29, 2016: The
bioeconomy company BRAIN AG (ISIN DE0005203947 / WKN 520394), the natural
product specialist AnalytiCon Discovery GmbH and Roquette, a global leader
in specialty food ingredients from plant-based raw materials, announced
today a strategic partnership under the form of a consortium by the name
DOLCE. Within this unique strategic partnership, the partners will jointly
develop natural sweeteners and sweet taste enhancers with the goal to
achieve sugar- and calorie reduction in a variety of food and beverages.
These developments will benefit the global market and will address pressing
needs in terms of sugar replacement.
Always striving for innovation, within the DOLCE consortium, Roquette
intends to benefit from the proprietary BRAIN screening technology and
AnalytiCon's access to a huge variety of all-natural ingredients with a
particular focus on edible plant material. Roquette's role will be to take
care of the late stage development, production and supply of the compounds
to different markets and application fields.
The goal of the DOLCE consortium is to develop cutting-edge natural sweet
taste enhancers and sweeteners for nutrition and improved food formulations
for their customers, and to deploy a brand strategy on the new solutions,
addressing the requirements of global customers. Many of the largest
Fortune 500 global consumer product goods companies (CPGC) are known to
have strong interest in this field, and the market for consumer goods and
beverages is expected to greatly benefit from the development of these new
sweetening solutions.
"In the field of food and beverages, there is a high demand for natural
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte